Cushman And Wakefield Ltd (CWK) valuation
Cushman And Wakefield P/E ratio history
Cushman And Wakefield trades at 45.9 times its earnings over the last twelve months and 8.5 times the earnings analysts expect over the next twelve. At its last 4 fiscal year ends its P/E ranged from 14.5 (year to Dec 2022) to 42.6 (year to Dec 2025), with a median of 21.8.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $16.19 | $0.38 | 42.6 | — |
| Dec 31, 2024 | $13.08 | $0.56 | 23.4 | 11.8 |
| Dec 31, 2023 | $10.80 | -$0.16 | n/m | — |
| Dec 31, 2022 | $12.46 | $0.86 | 14.5 | 6.0 |
| Dec 31, 2021 | $22.24 | $1.10 | 20.2 | — |
| Dec 31, 2020 | $14.83 | -$1.00 | n/m | — |
| Dec 31, 2019 | $20.44 | -$0.01 | n/m | — |
| Dec 31, 2018 | $14.47 | -$1.18 | n/m | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Cushman And Wakefield valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Cushman And WakefieldCWK | $3.12B | 45.9 | 8.5 | 0.3 |
| National Health Investors ReitNHI | $3.25B | 19.4 | 17.9 | 7.5 |
| Broadstone Net LeaseBNL | $3.28B | 22.5 | 24.8 | 6.8 |
| Curbline PropertiesCURB | $3.28B | 124.0 | 90.9 | 13.3 |
| Diamondrock HospitalityDRH | $2.91B | 19.5 | 20.2 | 2.6 |
| Independence RealtyIRT | $3.47B | 81.8 | 102.4 | 5.2 |
| Sl Green Realty ReitSLG | $3.58B | — | — | 3.5 |
| Lxp Industrial TrustLXP | $3.61B | 31.5 | 141.6 | 10.3 |
| Copt Defense PropertiesCDP | $3.78B | 23.3 | 22.9 | 4.8 |
| Peer median | 23.3 | 24.8 | 6.0 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: CWK financials · CWK returns
No forecast, no recommendation. This page describes Cushman And Wakefield Ltd from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.